Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...

Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 10% in the afternoon session after the company announced a 53% year-over-year increase in its Medicare Advantage membership and ...

Clover Health Investments (CLOV) drew fresh attention after reporting a 53% year-over-year jump in Medicare Advantage PPO membership to about 153,000 members, alongside improving economics, strong ...

Medicare Advantage (MA) insurer Clover Health is leaning on strong performance in the annual enrollment period and financial growth to turbocharge the company in the coming months.

Clover Health Investments Corp (NASDAQ: CLOV) stock is rising Wednesday after the company announced that it expects to achieve its first full-year GAAP net income profitability this year.